Table 1.
Relationship between RBM38 expression and clinicopathological features of 53 hepatocellular carcinoma (HCC) patients.
| Variables | N = 53 | RBM38 expression | χ2 | p value | |
|---|---|---|---|---|---|
|
|
|||||
| high | low | ||||
| Age (years) | |||||
|
| |||||
| ≤50 | 21 | 6 (11.3%) | 15 (28.3%) | 0.083 | 0.773 |
| >50 | 32 | 8 (15.1%) | 24 (45.3%) | ||
|
| |||||
| Gender | |||||
|
| |||||
| Male | 44 | 13 (24.5%) | 31 (58.5%) | 1.306 | 0.253 |
| Female | 9 | 1 (1.9%) | 8 (15.1%) | ||
|
| |||||
| Size of tumor (cm) | |||||
|
| |||||
| ≤5 | 32 | 7 (13.2%) | 25 (47.2%) | 0.856 | 0.355 |
| >5 | 21 | 7 (13.2%) | 14 (26.4%) | ||
|
| |||||
| Number of tumor | |||||
|
| |||||
| Single | 29 | 8 (15.1%) | 21 (39.6%) | 0.045 | 0.832 |
| Multiple | 24 | 6 (11.3%) | 18 (33.9%) | ||
|
| |||||
| Vascular invasion | |||||
|
| |||||
| Negative | 41 | 11 (20.8%) | 30 (56.6%) | 0.016 | 0.899 |
| Positive | 12 | 3 (5.7%) | 9 (17.0%) | ||
|
| |||||
| Pathological Grading | |||||
|
| |||||
| Well/Moderately | 25 | 5 (9.4%) | 20 (37.7%) | 1.002 | 0.317 |
| Poorly | 28 | 9 (17.0%) | 19 (35.8%) | ||
|
| |||||
| AFP (ng/mL) | |||||
|
| |||||
| ≤400 | 20 | 9 (17.0%) | 11 (20.8%) | 5.708 | 0.017 |
| >400 | 33 | 5 (9.4%) | 28 (52.8%) | ||
|
| |||||
| TBIL (μmol/L) | |||||
|
| |||||
| ≤20 | 33 | 10 (18.9%) | 23 (43.4%) | 0.680 | 0.410 |
| >20 | 20 | 4 (7.5%) | 16 (30.2%) | ||
AFP, alpha-fetoprotein; TBIL, total bilirubin; Statistical analyses were performed with Pearson’s chi-square test.